Treatment of Prostatitis
Treat acute bacterial prostatitis with fluoroquinolones (ciprofloxacin 500mg PO BID or levofloxacin) for 2-4 weeks in outpatients when local resistance is <10%, or use IV ceftriaxone plus doxycycline for hospitalized patients with severe illness. 1
Classification-Based Treatment Algorithm
The treatment approach depends entirely on which of the four categories your patient falls into 2:
Acute Bacterial Prostatitis
For outpatients:
- Start fluoroquinolones immediately (ciprofloxacin 500mg PO BID or levofloxacin) if local fluoroquinolone resistance is <10% 1
- Continue for 2-4 weeks total 1
- Obtain midstream urine culture and blood cultures before starting antibiotics to identify the causative organism 1, 3
For hospitalized patients with severe illness:
- Use IV ceftriaxone plus doxycycline 1
- Switch to oral fluoroquinolones once clinically improved 3
- Assess clinical response after 48-72 hours 3
Critical diagnostic maneuvers:
- Perform a gentle digital rectal examination to assess for tender, enlarged, or boggy prostate 1
- Never perform vigorous prostatic massage or manipulation due to bacteremia risk 1, 3
- Order transrectal ultrasound if the patient fails to respond after 48-72 hours to rule out prostatic abscess 1, 3
Chronic Bacterial Prostatitis
- Prescribe fluoroquinolones (levofloxacin or ciprofloxacin) for a minimum of 4 weeks 1
- Extend treatment duration if symptoms improve but are not fully resolved 1
- Use the Meares-Stamey 4-glass test (or simplified 2-specimen variant) to confirm diagnosis, requiring a 10-fold higher bacterial count in expressed prostatic secretions compared to midstream urine 1, 3
- Test for atypical pathogens (Chlamydia trachomatis, Mycoplasma species) when appropriate, as up to 74% of cases are caused by gram-negative organisms, particularly E. coli 1, 3
Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
This is NOT an infectious condition and requires completely different management:
- Prescribe alpha-blockers (tamsulosin or alfuzosin) as first-line therapy for patients with urinary symptoms, which provide NIH-CPSI score reduction of 4.8-10.8 points 1
- Combine alpha-blockers with anti-inflammatories and supportive measures (sitz baths, relaxants, psychological support) for optimal symptom relief 1
- Do NOT prescribe prolonged antibiotics without evidence of infection 1
Asymptomatic Inflammatory Prostatitis
- This is an incidental finding without symptoms and typically requires no treatment 2
Prostatic Abscess Management
- Drain via transrectal ultrasound-guided aspiration for confirmed abscesses 2
- Small abscesses may resolve with antibiotics alone 2
- Consider imaging in patients who fail to respond to antibiotics to rule out abscess formation 2
Critical Pitfalls to Avoid
- Never use amoxicillin/ampicillin empirically due to global resistance rates of 45-100% 1, 3
- Never perform vigorous prostatic massage in acute bacterial prostatitis due to bacteremia risk 1, 3
- Never stop antibiotics prematurely in bacterial prostatitis, as this leads to chronic infection 1, 3
- Never prescribe prolonged antibiotics for CP/CPPS without evidence of infection; focus on symptom management instead 1
- Always consider local resistance patterns when selecting empiric fluoroquinolone therapy, using them only if resistance is <10% 1, 3
Antibiotic Selection Rationale
Fluoroquinolones are first-line for bacterial prostatitis because they achieve excellent prostatic penetration with prostate:serum ratios of up to 4:1 2, and provide broad antimicrobial coverage against the gram-negative bacteria (E. coli, Klebsiella, Pseudomonas) responsible for 80-97% of acute cases 3. However, local resistance patterns must guide selection 2, 3.